Myriad Genetics (MYGN) Current Taxes (2014 - 2020)

Myriad Genetics (MYGN) has 7 years of Current Taxes data on file, last reported at $6.1 million in Q2 2020.

• Current Taxes for Q2 2020 came in at $6.1 million, up 103.33% year-over-year; the trailing twelve-month figure through Jun 2020 was $6.1 million (up 103.33% YoY), and the FY2020 annual result was $6.1 million, up 103.33% from the prior year.
• Current Taxes grew to $6.1 million in Q2 2020 per MYGN's latest filing, from $3.5 million in the prior quarter.
• Over five years, Current Taxes peaked at $9.8 million in Q3 2018 and troughed at $2.3 million in Q1 2016.
• A 5-year average of $4.6 million and a median of $3.6 million in 2019 frame the typical range for Current Taxes.
• The sharpest annual moves came in 2017 and 2018: Current Taxes surged 168.75% in 2017, then plunged 39.44% in 2018.
• A 5-year view of Current Taxes shows it stood at $3.0 million in 2016, then gained by 6.67% to $3.2 million in 2017, then soared by 53.12% to $4.9 million in 2018, then declined by 18.37% to $4.0 million in 2019, then surged by 52.5% to $6.1 million in 2020.
• Business Quant data shows MYGN's Current Taxes at $6.1 million in Q2 2020, $3.5 million in Q1 2020, and $4.0 million in Q4 2019.